Phospholamban regulates the Ca2+-ATPase through intramembrane interactions

Area of Science:

• Biochemistry
• Molecular Biology
• Cardiology

Background:

• Phospholamban (PLN) is known to regulate the cardiac sarcoplasmic reticulum Ca2+-ATPase (SERCA2a) via cytoplasmic interactions.
• Evidence for regulatory interactions within the transmembrane domains of PLN and SERCA2a is less clear.

Purpose of the Study:

• To investigate intramembrane interactions between phospholamban (PLN) and SERCA isoforms in the absence of cytoplasmic interactions.
• To elucidate the role of transmembrane domains of PLN in modulating SERCA2a activity.

Main Methods:

• Coexpression of SERCA isoforms with modified transmembrane sequences of PLN (e.g., Met-PLN28-52, HA-PLN28-52, PLN1-20-PLN30-52).
• Assessment of Ca2+ transport inhibition and apparent Ca2+ affinity.
• Use of antibodies to confirm construct orientation and reversibility of inhibition.

Main Results:

• Coexpression of PLN transmembrane sequences inhibited Ca2+ transport by reducing apparent Ca2+ affinity.
• Specific modifications to the PLN transmembrane sequence further decreased Ca2+ affinity without uncoupling transport from ATP hydrolysis.
• Inhibition was reversible and dependent on the presence and orientation of the inhibitory PLN constructs.

Conclusions:

• PLN modulates SERCA2a apparent Ca2+ affinity through intramembrane interactions.
• These intramembrane interactions are distinct from and can act in concert with cytoplasmic interactions.
• The findings highlight the importance of transmembrane domain interactions in PLN-SERCA regulation.